SJIA
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE (NCT05001737) | Swedish Orphan Biovitrum | 2021-12-15 |
Track SJIA automatically
Every clearance here is in the API, with alerts when new ones post.